Atricure Inc’s recently made public that its Chief Scientific Officer Doraiswamy Vinayak unloaded Company’s shares for reported $83600.0 on May 28 ’25. In the deal valued at $33.44 per share,2,500 shares were sold. As a result of this transaction, Doraiswamy Vinayak now holds 73,550 shares worth roughly $2.4 million.
Then, VINAYAK DORAISWAMY bought 2,500 shares, generating $83,600 in total proceeds.
Before that, Prange Karen sold 6,100 shares. Atricure Inc shares valued at $232,532 were divested by the Director at a price of $38.12 per share. As a result of the transaction, Prange Karen now holds 17,828 shares, worth roughly $0.58 million.
A number of analysts have revised their coverage, including Oppenheimer’s analysts, who increased its forecast for the stock in late April from “a Perform” to “an Outperform”. JMP Securities began covering ATRC with “Mkt outperform” recommendation on October 23, 2023. UBS started covering the stock on September 29, 2023. It rated ATRC as “a Buy”.
Price Performance Review of ATRC
On Tuesday, Atricure Inc [NASDAQ:ATRC] saw its stock jump 0.90% to $32.60. Over the last five days, the stock has lost -2.37%. Atricure Inc shares have risen nearly 6.68% since the year began. Nevertheless, the stocks have risen 55.46% over the past one year. While a 52-week high of $43.11 was reached on 01/29/25, a 52-week low of $18.94 was recorded on 05/01/25.
Levels Of Support And Resistance For ATRC Stock
The 24-hour chart illustrates a support level at 31.83, which if violated will result in even more drops to 31.05. On the upside, there is a resistance level at 33.24. A further resistance level may holdings at 33.87.
